As such, blocking of BLyS, which has been used as a therapeutic target in clinical trials for the treatment of autoimmune disorders such as systemic lupus erythematosus (SLE) [58], may also be efficient in modulating this balance. Here, TNFSF13B is linked to Autoimmunity.